Aeva Technologies, Inc. (AEVA) SEC Filings & Earnings Calls
EquiReason read 17 Aeva Technologies, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-06 — Total Revenue $6M (+11% y/y); Product Revenue $3M (-39% y/y); Professional Service Revenue $4M (+174% y/y).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 708.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
6 Aug 202610-QTotal Revenue $6M (+11% y/y); Product Revenue $3M (-39% y/y); Professional Service Revenue $4M (+174% y/y)open
Figures in the filing · each found in the filing text
| Total Revenue · Q2-2026 | $6M | +11% y/y |
| Product Revenue · Product · Q2-2026 | $3M | -39% y/y |
| Professional Service Revenue · Professional Service · Q2-2026 | $4M | +174% y/y |
| Gross Profit · Q2-2026 | $2M | |
| Net Loss · Q2-2026 | $-80M | -59% y/y |
| Cash and Cash Equivalents and Marketable Securities · 2026-06-30 | $178M | |
| Operating Cash Flow · H1-2026 | $-57M | -6% y/y |
Risks flagged
Pricing Pressure on Product Revenue
“Product revenue decreased by $1.7 million, or 39%, to $2.5 million during the three months ended June 30, 2026, from $4.2 million for the three months ended June 30, 2025. This decrease was primarily due to a lower average selling price of units sold.” · word for word
Dependence on Development-Stage Customers
“Our future performance will depend on our ability to deliver on economies of scale. Our customers will require that our perception solutions be manufactured and sold at per-unit prices that are competitive.” · word for word
Warrant Liability Volatility
“Change in fair value of warrant liabilities $(44,700) (2026) vs $(88,478) (2025) — significant non-cash volatility.” · word for word
5 Aug 20268-K · 2.02, 5.02Revenue $6M (+11% y/y); GAAP operating loss $35M (-1% y/y); Non-GAAP operating loss $26M (+4% y/y)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $6M | +11% y/y |
| GAAP operating loss · Q2-2026 | $35M | -1% y/y |
| Non-GAAP operating loss · Q2-2026 | $26M | +4% y/y |
| GAAP net loss per share · Q2-2026 | $1.23 | -65% y/y |
| Non-GAAP net loss per share · Q2-2026 | $0.41 | -7% y/y |
| Total available liquidity · Q2-2026 | $303M | |
| Cash, cash equivalents and marketable securities · Q2-2026 | $178M | |
| Weighted average shares outstanding · Q2-2026 | 64,700,000 |
Risks flagged
CFO departure creates execution risk during growth phase
“CFO Saurabh Sinha resigns effective Sept 5, 2026; interim CFO appointed.”
Dependence on new Optical Connectivity business for future growth; customer concentration risk
“First customer agreement for Optical Connectivity with a hyperscaler; initial deployment targeted for H2 2027.”
Continued operating losses and cash burn
“GAAP operating loss of $34.6M in Q2 2026; non-GAAP operating loss $26.0M.”
6 Jul 2026SC 13D/ASylebra Capital filed an amended Schedule 13D disclosing a 29.3% beneficial ownership stake in Aeva Technologies, including a $50M convertible note contribution to new funds.open
Figures in the filing · each found in the filing text
| Beneficial Ownership Percentage · 2026-06-30 | 29.3% | |
| Convertible Notes Principal Amount · 2026-06-30 | $50M |
Risks flagged
Concentrated ownership risk
“The Reporting Persons may be deemed to beneficially own an aggregate of 19,392,411 shares of Common Stock, representing approximately 29.3% of the outstanding Common Stock.” · word for word
6 Jul 2026SC 13D/ASylebra Capital filed an amended Schedule 13D disclosing a 29.3% beneficial ownership stake in Aeva Technologies, including a $50M convertible note contribution to new funds.open
Figures in the filing · each found in the filing text
| Beneficial Ownership Percentage · 2026-06-30 | 29.3% | |
| Convertible Notes Principal Amount · 2026-06-30 | $50M |
Risks flagged
Concentrated ownership risk
“The Reporting Persons may be deemed to beneficially own an aggregate of 19,392,411 shares of Common Stock, representing approximately 29.3% of the outstanding Common Stock.” · word for word
4 Jun 20268-K · 1.01, 8.01Aeva Technologies entered into an underwriting agreement to sell 4,494,382 shares at $22.25 per share, with an option for an additional 674,157 shares. Net proceeds expected ~$94.4M ($108.7M if option exercised).open
Figures in the filing · each found in the filing text
| Offering size (shares) · 2026-06-03 | 4,494,382 | |
| Offering price per share · 2026-06-03 | $22.25 | |
| Net proceeds (expected) · 2026-06-03 | $94M | |
| Net proceeds (max with overallotment) · 2026-06-03 | $109M |
Risks flagged
Share dilution from offering
“4,494,382 shares issued (up to 5,168,539 with overallotment) at $22.25/share.”
8 May 202610-QTotal revenues $6M (+86% y/y); Product revenue $2M (-2% y/y); Professional service revenue $4M (+332% y/y)open
Figures in the filing · each found in the filing text
| Total revenues · Q1-2026 | $6M | +86% y/y |
| Product revenue · Product · Q1-2026 | $2M | -2% y/y |
| Professional service revenue · Professional service · Q1-2026 | $4M | +332% y/y |
| Gross profit · Q1-2026 | $2M | +526% y/y |
| Net loss · Q1-2026 | $-35M | 0% y/y |
| Cash and cash equivalents and marketable securities · 2026-03-31 | $100M | |
| Cash used in operating activities · Q1-2026 | $-26M | -16% y/y |
| Accumulated deficit · 2026-03-31 | $792M |
Risks flagged
Cash burn and going concern risk
“To date, we have incurred negative cash flows from operating activities and incurred losses from operations as reflected in our accumulated deficit of $792.3 million as of March 31, 2026.” · word for word
Pricing pressure on product revenue
“Product revenue decreased by $0.1 million, or 2%, to $2.4 million ... primarily due to a lower average selling price of units sold.” · word for word
Dependence on customer development cycles
“The development cycles of our products with new customers varies widely depending on the application, market, customer and the complexity of the product, and can vary from several months to years depending on the industry.” · word for word
6 May 20268-K · 2.02Revenue $6M (+85% y/y); GAAP operating loss $35M (+15% y/y); Non-GAAP operating loss $26M (-0% y/y)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $6M | +85% y/y |
| GAAP operating loss · Q1-2026 | $35M | +15% y/y |
| Non-GAAP operating loss · Q1-2026 | $26M | -0% y/y |
| GAAP net loss per share · Q1-2026 | $0.56 | -13% y/y |
| Non-GAAP net loss per share · Q1-2026 | $0.41 | -9% y/y |
| Total available liquidity · 2026-03-31 | $225M | |
| Cash, cash equivalents and marketable securities · 2026-03-31 | $100M | |
| Weighted average shares outstanding · Q1-2026 | 62,800,000 |
Risks flagged
Continued operating losses; GAAP operating loss $35.1M, though non-GAAP loss stable YoY.
“GAAP operating loss of $35.1 million in Q1 2026, compared to GAAP operating loss of $30.4 million in Q1 2025.” · word for word
Dependence on automotive OEM program wins for future revenue growth; execution risk on production timelines.
“Delivered production intent Atlas sensors to Daimler Truck ... Delivered first Atlas Ultra sensors to the Top 10 European passenger OEM.” · word for word
29 Apr 2026DEF 14ANet loss $-145M; Net loss $-152M; Net loss $-149Mopen
Figures in the filing · each found in the filing text
| Net loss · FY2025 | $-145M | |
| Net loss · FY2024 | $-152M | |
| Net loss · FY2023 | $-149M | |
| TSR (cumulative) · FY2025 | $195.29 | |
| TSR (cumulative) · FY2024 | $69.85 | |
| TSR (cumulative) · FY2023 | $55.71 |
Risks flagged
Concentrated ownership and related-party risk
“Entities affiliated with Sylebra Capital LTD ... 16,228,553 ... 25.8%”
Significant stock-based compensation
“Stock Awards ... 7,180,000 ... for CEO and CTO each”
20 Mar 202610-KRisks named: Convertible Debt Repurchase Risk, Liquidity Risk from Convertible Notes, Concentrated Ownership Risk, Insider Share Pledge Disputeopen
Risks flagged
Convertible Debt Repurchase Risk
“Holders of the Notes have the right to require us to repurchase all or a portion of their Notes upon the occurrence of a 'fundamental change' before the maturity date at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest, if any.” · word for word
Liquidity Risk from Convertible Notes
“We may not have enough available cash, or be able to obtain sufficient financing, at a time we are required to repurchase the Notes.” · word for word
Concentrated Ownership Risk
“Our officers and directors, as well as entities they are affiliated with or control, beneficially own or control approximately 36.3% of our outstanding shares of common stock.” · word for word
Insider Share Pledge Dispute
“The beneficially owned shares outstanding does not include certain shares owned by Mr. Rezk that were pledged as collateral for a loan and this pledge is now the subject of a dispute.” · word for word
26 Feb 20268-K · 2.02Revenue $18M (+99% y/y); GAAP operating loss $-128M (+19% y/y); Non-GAAP operating loss $-102M (+17% y/y); Guidance: Expects another record revenue year in 2026earningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $18M | +99% y/y |
| GAAP operating loss · FY2025 | $-128M | +19% y/y |
| Non-GAAP operating loss · FY2025 | $-102M | +17% y/y |
| GAAP net loss per share · FY2025 | $-2.55 | +11% y/y |
| Non-GAAP net loss per share · FY2025 | $-1.75 | +19% y/y |
| Cash, cash equivalents and marketable securities · Q4-2025 | $122M |
Guidance
Expects another record revenue year in 2026
Management expects continued momentum with additional production program opportunities, scaling manufacturing, and another record revenue year.
Risks flagged
Continued operating losses and cash burn despite revenue growth.
“GAAP operating loss of $127.6 million for full year 2025; non-GAAP operating loss of $102.0 million.” · word for word
Dependence on automotive OEM production timelines (SOP 2028) for revenue inflection.
“Major production contract with targeted SOP in 2028; revenue inflection dependent on production ramp.”
3 Dec 20258-K · 7.01, 8.01Issued a Regulation FD disclosure (forward guidance or material update); disclosed a material event under other events (litigation, recall, contract loss, or major announcement)open
Risks flagged
Execution risk: SOP targeted for 2028; OEM may not pursue program as anticipated; early-stage company with history of losses.
“Forward-looking statements: risk that the OEM may not pursue the program as currently anticipated; Aeva is an early stage company with a history of operating losses.”
7 Nov 202510-QRevenue $4M (+59% y/y); Gross Profit $430,000.00; Net Income (Loss) $107Mopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $4M | +59% y/y |
| Gross Profit · Q3-2025 | $430000.00 | |
| Net Income (Loss) · Q3-2025 | $107M | |
| Cash and Cash Equivalents and Marketable Securities · 2025-09-30 | $49M | |
| Operating Cash Flow · 9M-2025 | $-93M |
Risks flagged
Cash Runway Risk
“As of September 30, 2025, we had cash and cash equivalents and marketable securities totaling $48.9 million.” · word for word
Commercialization Delay Risk
“The development cycles of our products with new customers varies widely depending on the application, market, customer and the complexity of the product, and can vary from several months to seven or more years depending on the industry.” · word for word
6 Nov 20258-K · 1.01, 2.03, 3.02Entered a material definitive agreement (acquisition, partnership, or major contract); took on a material direct financial obligation, increasing leverageopen
Risks flagged
Dilution risk from convertible notes
“Any Common Stock that may be issued upon conversion of the Notes will be issued in reliance upon Section 3(a)(9) of the Securities Act.” · word for word
Increased leverage from new debt
“Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.” · word for word
5 Nov 20258-K · 2.02Cash, Cash Equivalents and Marketable Securities $49M; Revenue $4M (+57% y/y); GAAP Operating Loss $-33M (-12% y/y)earningsopen
Figures in the filing · each found in the filing text
| Cash, Cash Equivalents and Marketable Securities · Q3-2025 | $49M | |
| Revenue · Q3-2025 | $4M | +57% y/y |
| GAAP Operating Loss · Q3-2025 | $-33M | -12% y/y |
| Non-GAAP Operating Loss · Q3-2025 | $-27M | -13% y/y |
| GAAP Basic Net Income per Share · Q3-2025 | $1.86 | |
| GAAP Diluted Net Loss per Share · Q3-2025 | $-0.52 | |
| Non-GAAP Basic and Diluted Net Loss per Share · Q3-2025 | $-0.46 | -16% y/y |
| Weighted Basic Average Shares Outstanding · Q3-2025 | 57,900,000 | |
| Weighted Diluted Average Shares Outstanding · Q3-2025 | 61,100,000 |
Risks flagged
Early-stage company with history of operating losses and may never achieve profitability.
“Aeva is an early stage company with a history of operating losses and may never achieve profitability.” · word for word
Dependence on OEM selection and series production awards; no assurance of definitive agreements or significant revenues.
“No assurance that any of our customers will ever complete testing and validation with us or that we will receive any billings or revenues in connection with such programs.” · word for word
Manufacturing scale-up risk: ability to manufacture at volumes and costs needed for commercial programs.
“The ability to manufacture at volumes and costs needed for commercial programs.” · word for word
Aeva Technologies, Inc. — questions
- What did Aeva Technologies, Inc. file recently?
- 17 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-06 — Total Revenue $6M (+11% y/y); Product Revenue $3M (-39% y/y); Professional Service Revenue $4M (+174% y/y)
Every figure on this page comes from Aeva Technologies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.